US › Healthcare

InspireMD Inc (NSPR)

US · Healthcare · Medical Devices

$0.76-1.69%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.8M

Revenue YoY

-0.4%

Net profit

$-14.3M

EPS

$-0.17

EPS estimate

$-0.20

Net margin

-808.8%

EPS came in at -0.17 against a street estimate of -0.20 — a beat of 15.0%.

Key statistics

Market cap

$37.0M

Forward P/E

11.7

P/B

1.16

Book value

$0.67

EPS (TTM)

$-0.61

52-week high

$2.57

52-week low

$0.63

50-day MA

$0.78

200-day MA

$1.31

Beta

0.82

Analyst view

Analysts rate InspireMD Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.33.

Shareholding

Insiders

19.98%

Institutions

46.31%

Largest institutional holders

Fund	Stake
Rosalind Advisors, Inc.	8.32%
Aberdeen Group PLC	7.88%
Nantahala Capital Management, LLC	7.20%
Orbimed Advisors LLC	6.68%
Parkman Healthcare Partners LLC	5.15%
Marshall Wace Asset Management Ltd	3.96%
Soleus Capital Management, L.P.	2.23%
PURA VIDA INVESTMENTS, LLC	0.96%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InspireMD Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.